URL: http://www.midas-pharma.com/de/950_en.asp

ICD Ajinomoto Co. Inc., Belgium.

ICD Ajinomoto Co. - an exclusive partner for Active Pharmaceutical Ingredients and Intermediates.

The Company:
Ajinomoto Co, Inc., was founded in 1909 in Japan. It was named after its trademark seasoning product, monosodium glutamate, marketed as Aji no Moto ("Essence of Taste“). Ajinomoto rapidly evolved from a food company into a diversified global player and world leader in the area of amino acid technology. Today, the whole Ajinomoto group is active in 23 countries and has approximately 25,000 employees.

ICD (Intermediate Chemicals Department) Ajinomoto is a business sub-unit of Ajinomoto's AminoScience Division. ICD's specialties are amino acid derivatives, nucleoside derivatives and chiral key intermediates. Its expertise in both organic synthesis and advanced enzymatic technology results from almost one hundred years of company history. Extensive know-how, innovative solutions, commitment and efficiency mark Ajinomoto's work. The ICD-Team is specialized in developing novel customized products according to specific needs of the client using state-of-the-art technology.

Specific Strengths:
The well proven unique manufacturing procedure of ICD is a successful merge of their knowledge and superior technology in

The merge results in a wide product portfolio of

Further Valuable Information:
ICD's main production site is the Tokai plant in Japan. The Tokai plant has been inspected by regulatory agencies (including the US-FDA) and audited by numerous pharmaceutical companies. Fulfillment of FDA standards and cGMP compliance, in addition to ICD's high value of strong regulatory competence and analytical support, make ICD Ajinomoto an entrusted partner of choice.

Contact us:

Ajinomoto Co., Inc.
Intermediate Chemicals Department (ICD)
Industrial Research Park - Fleming
1348 Louvain-la-Neuve
Belgium

www.ajinomoto.co.jp/amino/e_aminoscience/ICD/index.html

 
© Midas Pharma GmbH - all rights reserved